Aarti Drugs advances on incorporating subsidiary in U.A.E.

07 Jan 2020 Evaluate

Aarti Drugs is currently trading at Rs. 568.00, up by 6.85 points or 1.22% from its previous closing of Rs. 561.15 on the BSE.

The scrip opened at Rs. 568.00 and has touched a high and low of Rs. 568.00 and Rs. 568.00 respectively. So far 294 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 705.00 on 11-Mar-2019 and a 52 week low of Rs. 419.30 on 05-Aug-2019.

Last one week high and low of the scrip stood at Rs. 598.75 and Rs. 558.40 respectively. The current market cap of the company is Rs. 1307.48 crore.

The promoters holding in the company stood at 61.64% while Institutions and Non-Institutions held 5.35% and 33.01% respectively.

Aarti Drugs has incorporated a Wholly Owned Subsidiary (WOS) Company namely 'Pinnacle Life Science LLC' registered with International Free Zone Authority, Fujairah at United Arab Emirates (U.A.E.) on January 5, 2020.

Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals.

Aarti Drugs Share Price

404.95 -3.35 (-0.82%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×